Title : Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease - Van Dam_2008_Psychopharmacology.(Berl)_197_37 |
Author(s) : Van Dam D , Coen K , De Deyn PP |
Ref : Psychopharmacology (Berl) , 197 :37 , 2008 |
Abstract : |
PubMedSearch : Van Dam_2008_Psychopharmacology.(Berl)_197_37 |
PubMedID: 18008065 |
Title : Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model - Van Dam_2005_Psychopharmacology.(Berl)_180_177 |
Author(s) : Van Dam D , Abramowski D , Staufenbiel M , De Deyn PP |
Ref : Psychopharmacology (Berl) , 180 :177 , 2005 |
Abstract : |
PubMedSearch : Van Dam_2005_Psychopharmacology.(Berl)_180_177 |
PubMedID: 15654502 |
Title : Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models - Van Dam_2005_Neurochem.Int_46_409 |
Author(s) : Van Dam D , Marescau B , Engelborghs S , Cremers T , Mulder J , Staufenbiel M , De Deyn PP |
Ref : Neurochem Int , 46 :409 , 2005 |
Abstract : |
PubMedSearch : Van Dam_2005_Neurochem.Int_46_409 |
PubMedID: 15737439 |